CEREXA INC.
Cerexa is a biopharmaceutical company focused on the development of a portfolio of novel anti-infective therapies for the treatment of serious and life-threatening infections. The companyโs product portfolio includes Ceftaroline AcetateCeftaroline, an injectable cephalosporin that is used for the treatment of bacterial infections caused by gram-positive and gram-negative pathogens.
CEREXA INC.
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2005-01-01
Address:
New York, New York, United States
Country:
United States
Total Employee:
5001+
Status:
Active
Contact:
(510)285-9200
Total Funding:
50 M USD
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Current Advisors List
Founder
Investors List
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series A - Cerexa Inc.
OrbiMed
OrbiMed investment in Series A - Cerexa Inc.
Montreux Equity Partners
Montreux Equity Partners investment in Series A - Cerexa Inc.
EGS Healthcare Capital Partners
EGS Healthcare Capital Partners investment in Series A - Cerexa Inc.
Canaan Partners
Canaan Partners investment in Series A - Cerexa Inc.
CDIB BioScience Ventures
CDIB BioScience Ventures investment in Series A - Cerexa Inc.
A. M. Pappas & Associates
A. M. Pappas & Associates investment in Series A - Cerexa Inc.
New Leaf Venture Partners
New Leaf Venture Partners investment in Series A - Cerexa Inc.
Domain Associates
Domain Associates investment in Series A - Cerexa Inc.
More informations about "Cerexa Inc."
Cerexa, Inc. To Be Acquired By Forest Laboratories, Inc. For $480 ...
Dec 14, 2006 Cerexa licensed the global development and commercialization rights to ME1036 from Meiji Seika Kaisha Ltd. About Forest Laboratories and Its Products Forest Laboratories โฆSee details»
Cerexa Company Profile 2024: Valuation, Investors, Acquisition
Cerexa General Information Description. Developer of anti-infective therapies for the treatment of antibiotic-resistant infections. The company provides an injectable cephalosporin that is used โฆSee details»
Cerexa, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Cerexa, Inc. with its drug pipeline, therapeutic area, technology platform, 13 clinical trials, 4 news, and 53 literature.See details»
Cerexa Inc. - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Aug 23, 2005: Series A - โฆSee details»
Cerexa Inc. - Contacts, Employees, Board Members, Advisors
Cerexa is a biopharmaceutical company produces a portfolio of anti-infective therapies for the treatment of life-threatening infections. Search Crunchbase. Start Free Trial . Chrome โฆSee details»
Cerexa Inc - Company Profile and News - Bloomberg Markets
Cerexa, Inc. manufactures medical products. The Company discovers, develops, and commercializes anti-infective therapies for the treatment of serious and life-threatening infections.See details»
Cerexa - Products, Competitors, Financials, Employees, โฆ
Feb 6, 2013 Cerexa Inc., a biotech firm, is expanding its office presence in 2100 Franklin in Oakland to 50,000 square feet.The expansion comes four years after the company moved to โฆSee details»
Cerexa, Inc. - VentureRadar
Cerexa is an innovative biopharmaceutical company focused on developing therapies for the treatment of serious and lifeโthreatening infections. Cerexa was sold to Forest Laboratories in โฆSee details»
Forest Laboratories, Inc. Announces Completion of Acquisition Of โฆ
Jan 12, 2007 CONTACT: Charles E. Triano, Vice President - Investor Relations, of ForestLaboratories, Inc., +1-212-224-6714, [email protected]See details»
Cerexa - Canaan
Cerexa is an innovative biopharmaceutical company focused on developing therapies for the treatment of serious and lifeโthreatening infections. Cerexa was sold to Forest Laboratories in โฆSee details»
CEREXA Company Profile | Oakland, CA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CEREXA of Oakland, CA. Get the latest business insights from Dun & Bradstreet.See details»
Cerexa - Pappas Capital
Cerexa developed hospital-based anti-infective therapies for the treatment of patients with serious, life-threatening infections. Formed in the spring of 2005 as a spin-out from Peninsula โฆSee details»
Cerexa Inc. - Crunchbase
Cerexa is a biopharmaceutical company produces a portfolio of anti-infective therapies for the treatment of life-threatening infections. Search Crunchbase. Start Free Trial . Chrome โฆSee details»
Cerexa, Inc. Announces Completion Enrollment In Ceftaroline
Apr 5, 2006 Cerexa, Inc., located in Alameda, California, is an innovation driven, biopharmaceutical company committed to developing and commercializing a growing portfolio โฆSee details»
Staff & Board - SCAN of Northern Virginia
Vice President and Chief Financial Officer, NAIOP, Inc. Terry L Wright, LCSW ACHS Truancy Outreach and Attendance Specialist, Alexandria City Public Schools Council of Philanthropic โฆSee details»
NEUROLOGY SERVICES, INC. NPI 1902877046 Psychiatry
Jan 27, 2006 NPI Profile for Neurology Services, Inc. in 2296 Opitz Blvd Suite 360 Woodbridge, Va 22191. Phone: (703) 878-0600 . Taxonomy 2084N0400X Accepts: Medicare, Medicaid and โฆSee details»
Cerexa Inc. - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Cerexa is a biopharmaceutical company produces a portfolio of anti-infective therapies for the treatment of life-threatening infections. Search Crunchbase. Start Free Trial . Chrome โฆSee details»
Victory By Faith Church | Woodbridge VA - Facebook
Victory By Faith Church, Woodbridge, Virginia. 419 likes · 10 talking about this · 488 were here. At Victory by Faith Church we are impacting and...See details»
Virginia Programs and Advocacy Campaigns - We Are Casa
Woodbridge Welcome Center. 2359 Research Ct Woodbridge, VA 22192. Office Number: (571)421-2211See details»